FDA Launches START Program to Accelerate Development of Therapies for Rare Diseases
The FDA has launched the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) program, applying [...]
Novo Nordisk Invests $6 Billion in API Production Expansion to Meet High Demand
Novo Nordisk is investing over $6 billion to expand Denmark's active pharmaceutical ingredients (API) production capacity. [...]
Pfizer Announces Cost-Cutting Measures as Covid Vaccine and Antiviral Sales Decline
Pfizer has announced plans for a company-wide cost-cutting initiative this year and next due to expected [...]
Public Health Policies Aligned with Climate Change Mitigation: An Investment for Health and Economic Benefits
Investing in public health policies aligning with climate change mitigation measures is financially beneficial and crucial for human and planetary [...]
Medicare Price Negotiations for Drugs Begin in 2026: Eliquis Among Most Impacted
The Centers for Medicare & Medicaid Services (CMS) has disclosed a list of the initial ten drugs that will undergo [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
NHS’s MedTech Strategy: Building Resilience, Innovation, Infrastructure, and Focused Markets for UK’s Future in Medical Technology
The Med-Tech Innovation Expo in June presented the NHS's medtech strategy. The NHS released this strategy in February 2023 and [...]
Proposing a Revolution in American Healthcare: Universal Basic Health Coverage
MIT Professors Amy Finkelstein and Liran Einav have proposed a total overhaul of the U.S. health insurance system, advocating for [...]
Medical Affairs Outsourcing Market Forecasted to Reach $3.28B by 2027
The global Medical Affairs Outsourcing Market is forecast to reach $3,287.12 million by 2027 from $1,415.00 million in 2019, growing [...]
Economists Suggest That Universal Coverage Is Already Possible for the US: What Obstacles Still Stand in the Way?
The current state of health insurance in the U.S. needs to be revised, even for insured Americans who face the [...]
Sequoia Project and AHIMA Launch Health Data Usability Project
The Sequoia Project and the American Health Information Management Association (AHIMA) have partnered on the initiative "Data Usability Taking Root." [...]
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
Expert, Deepak Sahu answers questions on developing HEOR studies for generating short- and long-term effectiveness data for medical technology.
Podcast Q&A: Designing Causal Inference Studies Using Real-World Data
An expert panel answers questions on causal inference and designing these studies using real-world healthcare data.
Podcast Q&A: Evidence Generation Planning
Experts answer questions on evidence generation planning for clinical and commercial success and improvement of patient outcomes.
Industry Groups Challenge Readiness of ICER’s Value Framework
Healthcare is all about making decisions. Who to treat? When to treat? How to treat? How long to treat? How [...]
The New Decision Analysis Guidance from ISPOR: How it is Like HouseHunters
'Multiple criteria decision analysis' is a crummy name for a great concept (aren't all big decisions analyzed using multiple criteria?). [...]
WHEN 1+1=3: HOW ELECTRONIC HEALTH RECORDS AND CLAIMS CAN BE USED SYNERGISTICALLY
Sponsored blog posting by DaVita Clinical Research. 1. Combining Drug Development with Real-World Data Analytics DaVita Clinical Research® (DCR®), a [...]
